Lindbrook Capital’s Orthofix Medical OFIX Stock Holding History

Lindbrook Capital’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.5K	Hold	92	–	–	﹤0.01%	2364
2024 Q4	$1.61K	Hold	92	–	–	﹤0.01%	2368
2024 Q3	$1.44K	Hold	92	–	–	﹤0.01%	2429
2024 Q2	$1.22K	Hold	92	–	–	﹤0.01%	2456
2024 Q1	$1.34K	Hold	92	–	–	﹤0.01%	2359
2023 Q4	$1.24K	Sell	92 -16	-15%	-$188	﹤0.01%	2417
2023 Q3	$1.39K	Buy	+108	New	+$1.94K	﹤0.01%	2250
2022 Q4	–	Sell	-305	Closed	-$6K	–	2955
2022 Q3	$6K	Buy	+305	New	+$6.86K	﹤0.01%	1578
2022 Q2	–	Sell	-48	Closed	-$1.38K	–	2680
2022 Q1	$2K	Hold	48	–	–	﹤0.01%	2042
2021 Q4	$1K	Buy	+48	New	+$1.6K	﹤0.01%	1963
2020 Q2	–	Sell	-36	Closed	-$1K	–	1841
2020 Q1	$1K	Buy	+36	New	+$1.39K	﹤0.01%	1516

Other funds holding OFIX

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lindbrook Capital's OFIX Position: Q1 2025 in Review

Lindbrook Capital held its Orthofix Medical (OFIX) position steady in Q1 2025 at 92 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

Lindbrook Capital first reported a position in OFIX in Q1 2020 and has held it in 11 quarters since. The position peaked at $6K in Q3 2022. 160 funds tracked by Wall St. Rank hold OFIX as of Q1 2025.

Lindbrook Capital held 92 shares of Orthofix Medical worth $1.5K as of Q1 2025.
Lindbrook Capital left its Orthofix Medical share count unchanged in Q1 2025.
Orthofix Medical made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2364 holding.
Lindbrook Capital first reported a position in Orthofix Medical in Q1 2020 and has held it in 11 quarters since.
Lindbrook Capital's Orthofix Medical position peaked at $6K in Q3 2022.
160 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.